Correlation between chronic rhinosinusitis and laryngopharyngeal reflux

Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2018, Vol 8, Issue 4

Abstract

Background: Chronic rhinosinusitis (CRS) is a major Ear, Nose and Throat disease and there are higher numbers of refractory cases poorly responding to medical and surgical treatment. Laryngopharyngeal reflux (LPR) is said to be the important cause for same. Aims and Objectives: This study aims to study the incidence of LPR in patients of refractory CRS. This study also aims to study the impact of proton pump inhibitors (PPI) (effective treatment of LPR) given as adjuvant therapy along with functional endoscopic sinus surgery (FESS) in patients with refractory CRS. Materials and Methods: A total of 40 patients of refractory CRS taken up for the study were evaluated for signs and symptoms of LPR. They were then divided into two groups of 20 each - study group and control group. All the patients in both groups were evaluated for signs and symptoms of CRS. All these patients underwent FESS. Post-surgery patients in the study group were given intranasal steroids (INS) along with PPI (tablet pantoprazole) whereas in control group were put on INS without PPI. The patients were followed monthly for 3 months for improvement in signs and symptoms of CRS and patient’s relief and comfortability levels. Results: 45% of patients of refractory CRS had LPR with the posterior larynx being mainly involved. The major signs and symptoms of CRS were nasal obstruction, nasal discharge, and nasal polyps. There was more improvement in nasal obstruction, nasal discharge, and post-nasal discharge in patients of study group with PPI as compared to control group without PPI. There was better relief of symptoms in patients given PPI as compared to control group and this improvement was more marked at 3rd post-operative visit after 3 months. Conclusion: There is a strong association between refractory CRS and LPR. PPI are an effective drug for refractory CRS when given as adjuvant therapy along with FESS.

Authors and Affiliations

Manpreet Singh Nanda, Mandeep Kaur, Vipan Gupta

Keywords

Related Articles

Comparison of efficacy and safety of metformin and vildagliptin versus metformin and glimepiride in patients of Type 2 diabetes mellitus

Background: Diabetes mellitus is a heterogeneous chronic metabolic disorder principally characterized by persistent hyperglycemia resulting from defects in insulin action and/or insulin secretion. In course of time, prol...

The effect of hydroalcoholic extract of Mentha piperita on pentylenetetrazol-induced convulsion in mice

Background: Convulsion is one of the most important disorders of the central nervous system. On account of their lower side effects, the use of medical herbs for treating diseases, including convulsion, is on the rise. A...

A comparative study of lung function of rowers and runners of Manipur

Background: Prolonged training as in trained athletes results in the overall increase in muscular mass, metabolic power, and strength which also includes respiratory muscles. Enhancement of the respiratory muscle mass an...

 Classical autonomic function tests in patients with type 2 diabetes mellitus and healthy volunteers: A comparative study

 Background: The incidence of autonomic dysfunction has increased in the presence of type 2 diabetes mellitus and various tools have been developed for assessing it. Classical autonomic function tests are one among...

Evaluation of cardiovascular autonomic reactivity by cold pressor test in thyroid dysfunction in adults: A prospective case-control study

Background:Changes, in thyroid status, have pronounced effects on cardiovascular system reflecting autonomic dysfunction and increased morbidity. Exact interaction between autonomic nervous activity and thyroid hormones...

Download PDF file
  • EP ID EP487788
  • DOI 10.5455/njppp.2018.8.1145801122017
  • Views 98
  • Downloads 0

How To Cite

Manpreet Singh Nanda, Mandeep Kaur, Vipan Gupta (2018). Correlation between chronic rhinosinusitis and laryngopharyngeal reflux. National Journal of Physiology, Pharmacy and Pharmacology, 8(4), 544-549. https://europub.co.uk/articles/-A-487788